This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Oct;13(10):1436-1437.

doi: 10.1016/j.jtho.2018.07.007.

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Dean A Fennell¹

Affiliations

PMID: 30244849
DOI: 10.1016/j.jtho.2018.07.007

Free article

Editorial

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Dean A Fennell. J Thorac Oncol. 2018 Oct.

Free article

. 2018 Oct;13(10):1436-1437.

doi: 10.1016/j.jtho.2018.07.007.

Author

Dean A Fennell¹

Affiliation

¹ Thoracic Medical Oncology, University of Leicester & Leicester University Hospital, Leicester, United Kingdom. Electronic address: df132@le.ac.uk.

PMID: 30244849
DOI: 10.1016/j.jtho.2018.07.007

No abstract available

PubMed Disclaimer

Comment on

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma.
Quispel-Janssen J, van der Noort V, de Vries JF, Zimmerman M, Lalezari F, Thunnissen E, Monkhorst K, Schouten R, Schunselaar L, Disselhorst M, Klomp H, Hartemink K, Burgers S, Buikhuisen W, Baas P. Quispel-Janssen J, et al. J Thorac Oncol. 2018 Oct;13(10):1569-1576. doi: 10.1016/j.jtho.2018.05.038. Epub 2018 Jun 14. J Thorac Oncol. 2018. PMID: 29908324 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information